STAT+: Competition for obesity drugs, clinical blind spots, and more news from ADA

Article excerpt

STAT News reports from the American Diabetes Association's annual conference, covering three major healthcare developments. Competition among obesity drug makers is intensifying, while researchers are flagging clinical blind spots around eating disorders in patients taking weight-loss medications. A BCG vaccine update and clarification about a police incident at the conference round out the day's reporting from the diabetes field's largest gathering.